Trium Capital LLP Nevro Corp Transaction History
Trium Capital LLP
- $801 Million
- Q1 2025
A detailed history of Trium Capital LLP transactions in Nevro Corp stock. As of the latest transaction made, Trium Capital LLP holds 778,990 shares of NVRO stock, worth $4.55 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
778,990Holding current value
$4.55 Million% of portfolio
0.57%Shares
1 transactions
Others Institutions Holding NVRO
# of Institutions
146Shares Held
37.7MCall Options Held
622KPut Options Held
1.39M-
Arrow Mark Colorado Holdings LLC Denver, CO4.36MShares$25.5 Million0.24% of portfolio
-
Armistice Capital, LLC New York, NY3.74MShares$21.8 Million0.2% of portfolio
-
Black Rock Inc. New York, NY3.6MShares$21 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$12 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.8MShares$10.5 Million0.01% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $207M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...